Tony Lahoutte
9Patents
2h-index
21Co-inventors
43Inventor score
Filing activity: May 24, 2012 → Mar 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9913920B2 | Targeting and in vivo imaging of tumor-associated macrophages | Chemistry; Metallurgy | 7 | Active |
| US9855348B2 | Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US9637542B2 | CX3CR1-targeting imaging agents and their use in the diagnosis and treatment of disease | Physics | 2 | Active |
| US9101674B2 | Targeting and in vivo imaging of tumor-associated macrophages | Chemistry; Metallurgy | 2 | Active |
| US9771423B2 | Anti-VCAM-1 nanobodies | Chemistry; Metallurgy | 1 | Active |
| US9556273B2 | Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages | Chemistry; Metallurgy | 0 | Active |
| US11660356B2 | Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response | Physics | 0 | Active |
| US11298433B2 | Radiolabelled antibody fragments for use in treating cancer | Chemistry; Metallurgy | 0 | Active |
| US9617339B2 | Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.